Skip to main content
. 2022 Oct 5;160(1):209–219. doi: 10.1007/s11060-022-04138-w

Table 1.

Characteristics of primary brain and other CNS tumors stratified by behavior and time period of diagnosis (NPCR Survival Data: Data Provided by CDC's National Program of Cancer Registries SEER*Stat Database: NPCR Survival Analytic file, 2004-2017)*

Characteristic Malignanta Non-malignant
2004–2007
N = 61,391 n(%)
2008–2012
N = 79,918 n(%)
2013–2017
N = 84,376 n(%)
2004–2007
N = 140,038 n(%)
2008–2012
N = 220,879 n(%)
2013–2017
N = 254,828 n(%)
Age group
 0–14 5,189 (8.5%) 6,739 (8.4%) 7,009 (8.3%) 5,008 (3.6%) 7,270 (3.3%) 8,026 (3.1%)
 15–39 9,587 (16%) 12,125 (15%) 12,247 (15%) 22,662 (16%) 34,500 (16%) 37,866 (15%)
 40–64 25,641 (42%) 33,611 (42%) 33,990 (40%) 60,517 (43%) 94,140 (43%) 104,220 (41%)
  65+ 20,974 (34%) 27,443 (34%) 31,130 (37%) 51,851 (37%) 84,969 (38%) 104,716 (41%)
Sex
 Female 27,314 (44%) 35,292 (44%) 37,069 (44%) 90,460 (65%) 142,435 (64%) 163,108 (64%)
 Male 34,077 (56%) 44,626 (56%) 47,307 (56%) 49,578 (35%) 78,444 (36%) 91,720 (36%)
Race/ethnicity
 Non-Hispanic White 48,913 (80%) 62,268 (78%) 64,272 (76%) 102,140 (73%) 156,277 (71%) 175,158 (69%)
 Non-Hispanic Black 4,380 (7.1%) 5,930 (7.4%) 6,279 (7.4%) 16,193 (12%) 27,827 (13%) 33,051 (13%)
 Non-Hispanic Other 1,884 (3.1%) 2,986 (3.7%) 3,552 (4.2%) 5,627 (4.0%) 9,672 (4.4%) 13,052 (5.1%)
 Hispanic (all races) 5,921 (9.6%) 8,314 (10%) 9,739 (12%) 14,617 (10%) 24,898 (11%) 30,818 (12%)
 Unknown 293 (0.5%) 420 (0.5%) 534 (0.6%) 1,461 (1.0%) 2,205 (1.0%) 2,749 (1.1%)
Treatment pattern
 No treatment 9,672 (16%) 12,081 (15%) 11,788 (14%) 58,098 (41%) 111,536 (50%) 139,009 (55%)
 Radiation only 7,942 (13%) 9,566 (12%) 8,873 (11%) 8,329 (5.9%) 11,238 (5.1%) 10,474 (4.1%)
 Surgery and radiation 23,591 (38%) 32,988 (41%) 37,402 (44%) 3,946 (2.8%) 5,299 (2.4%) 5,809 (2.3%)
 Surgery only 12,136 (20%) 15,028 (19%) 14,190 (17%) 58,582 (42%) 74,500 (34%) 73,505 (29%)
 Unknown 8,050 (13%) 10,255 (13%) 12,123 (14%) 11,083 (7.9%) 18,306 (8.3%) 26,031 (10%)

*Differences in distribution are significant but not reported due to lack of clinical relevance

aIndividuals were classified as having malignant or non-malignant tumors based on the categories present in Table 2 of the CBTRUS Statistical Report [23]